PRGX GLOBAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2019
|
|
2018
|
|
2017
|
Cash flows from operating activities:
|
|
|
|
|
|
|
Net (loss) income
|
|
$
|
(13,720
|
)
|
|
$
|
4,593
|
|
|
$
|
3,184
|
|
Adjustments to reconcile net earnings to net cash provided by operating activities:
|
|
|
|
|
|
|
Impairment charges
|
|
10,073
|
|
|
—
|
|
|
—
|
|
Depreciation and amortization
|
|
13,446
|
|
|
10,766
|
|
|
8,203
|
|
Operating lease right-of-use asset
|
|
4,347
|
|
|
—
|
|
|
—
|
|
Amortization of deferred loan costs
|
|
126
|
|
|
53
|
|
|
85
|
|
Noncash interest expense
|
|
286
|
|
|
961
|
|
|
1,215
|
|
Stock-based compensation expense
|
|
4,930
|
|
|
5,056
|
|
|
7,052
|
|
Foreign currency transaction losses (gains) on short-term intercompany balances
|
|
298
|
|
|
1,002
|
|
|
(2,190
|
)
|
Income taxes
|
|
(425
|
)
|
|
(1,321
|
)
|
|
731
|
|
Changes in fair value of contingent consideration
|
|
(250
|
)
|
|
(1,628
|
)
|
|
(2,283
|
)
|
Changes in operating assets and liabilities, net of business acquisitions:
|
|
|
|
|
|
|
Billed receivables
|
|
5,705
|
|
|
(8,639
|
)
|
|
(3,949
|
)
|
Unbilled receivables
|
|
(1,598
|
)
|
|
(992
|
)
|
|
(469
|
)
|
Prepaid expenses and other current assets
|
|
(2,563
|
)
|
|
2,404
|
|
|
(417
|
)
|
Operating lease liabilities
|
|
(4,484
|
)
|
|
(229
|
)
|
|
(57
|
)
|
Accounts payable and accrued expenses
|
|
(1,239
|
)
|
|
(3,275
|
)
|
|
815
|
|
Accrued payroll and related expenses
|
|
(2,147
|
)
|
|
778
|
|
|
975
|
|
Refund liabilities
|
|
(2,075
|
)
|
|
(2,112
|
)
|
|
115
|
|
Deferred revenue
|
|
(210
|
)
|
|
1,036
|
|
|
101
|
|
Long-term incentive compensation payout
|
|
—
|
|
|
(6,378
|
)
|
|
—
|
|
Other long-term liabilities
|
|
—
|
|
|
351
|
|
|
353
|
|
Net cash provided by operating activities
|
|
10,500
|
|
|
2,426
|
|
|
13,464
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
Business acquisition, net of cash acquired
|
|
—
|
|
|
19
|
|
|
(10,128
|
)
|
Capital expenditures for property, equipment and software, net of disposal proceeds
|
|
(15,027
|
)
|
|
(10,398
|
)
|
|
(9,355
|
)
|
Net cash used in investing activities
|
|
(15,027
|
)
|
|
(10,379
|
)
|
|
(19,483
|
)
|
Cash flows from financing activities:
|
|
|
|
|
|
|
Repayments of long-term debt
|
|
(11,000
|
)
|
|
(13,500
|
)
|
|
66
|
|
Payment of deferred loan costs
|
|
(472
|
)
|
|
(38
|
)
|
|
(155
|
)
|
Proceeds from credit facility
|
|
26,400
|
|
|
21,500
|
|
|
10,000
|
|
Payment of earnout liability related to business acquisitions
|
|
(4,229
|
)
|
|
(4,000
|
)
|
|
—
|
|
Repurchases of common stock
|
|
(4,653
|
)
|
|
(4,069
|
)
|
|
—
|
|
Restricted stock repurchased from employees for withholding taxes
|
|
(802
|
)
|
|
(1,281
|
)
|
|
(100
|
)
|
Proceeds from option exercises
|
|
219
|
|
|
4,422
|
|
|
1,172
|
|
Net cash provided by financing activities
|
|
5,463
|
|
|
3,034
|
|
|
10,983
|
|
Effect of exchange rates on cash and cash equivalents
|
|
73
|
|
|
64
|
|
|
(1,860
|
)
|
Net increase (decrease) in cash and cash equivalents
|
|
1,009
|
|
|
(4,855
|
)
|
|
3,104
|
|
Cash, cash equivalents and restricted cash at beginning of period
|
|
14,019
|
|
|
18,874
|
|
|
15,770
|
|
Cash and cash equivalents at end of period
|
|
$
|
15,028
|
|
|
$
|
14,019
|
|
|
$
|
18,874
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
|
Cash paid during the period for interest
|
|
$
|
1,117
|
|
|
$
|
681
|
|
|
$
|
434
|
|
Cash paid during the period for income taxes, net of refunds received
|
|
$
|
2,440
|
|
|
$
|
3,255
|
|
|
$
|
2,929
|
|
|
|
|
|
|
|
|
Noncash investing activities:
|
|
|
|
|
|
|
Fair value of contingent consideration liabilities at the date of acquisition
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5,954
|
|
Capital expenditures for property, equipment, and software not paid by year-end
|
|
$
|
17
|
|
|
$
|
1,954
|
|
|
$
|
365
|
|
See accompanying Notes to Consolidated Financial Statements.
(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION
(a) Description of Business and Basis of Presentation
Description of Business
The principal business of PRGX Global, Inc. and subsidiaries is providing recovery audit and spend analytics services designed to improve our clients' source-to-pay ("S2P") business processes. PRGX also provides services adjacent to recovery audit services, including supplier information management ("SIM"), data transformation and associated advisory services to a similar client base. These businesses include, but are not limited to:
|
|
•
|
retailers such as discount, department, specialty, pharmacy and grocery stores, and wholesalers who sell to these retailers; and
|
|
|
•
|
business enterprises other than retailers such as manufacturers, financial services firms, pharmaceutical companies, and resource companies such as oil and gas companies.
|
Except as otherwise indicated or unless the context otherwise requires, “PRGX,” “we,” “us,” “our” and the “Company” refer to PRGX Global, Inc. and its subsidiaries. PRGX currently provides services to clients in over 30 countries across a multitude of industries.
Basis of Presentation
During the fourth quarter of 2015 we discontinued the Healthcare Claims Recovery Audit ("HCRA") business. The results of our continuing and discontinued operations for the years ended December 31, 2019, 2018 and 2017 are presented in accordance with ASC 205-20, Presentation of Financial Statements - Discontinued Operations.
The consolidated financial statements include the financial statements of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these consolidated financial statements in conformity with U.S. GAAP. Actual results could differ from those estimates.
(b) Revision of Prior Period Financial Statements
In connection with the preparation of the Company's consolidated financial statements required to be included in the Annual Report on Form 10-K for the year ended December 31, 2019, management identified an error in the Company's consolidated statement of comprehensive (loss) income for the year ended December 31, 2018. Based on an analysis of quantitative and qualitative factors, the Company concluded that the error was not material to the Company’s previously filed financial statements. The foreign currency translation adjustment in the statement of comprehensive (loss) income was disclosed as income of $1,128 instead of a loss of $1,128, and comprehensive income was previously reported as $5,721 instead of $3,465. These revisions are included herein. The amount was properly reported in the consolidated statement of shareholders’ equity and did not impact any other aspects of the consolidated financial statements.
(c) Revenue Recognition, Billed and Unbilled Receivables, and Refund Liabilities
Revenue Recognition, Billed and Unbilled Receivables
The Company recognizes revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To adhere to this core principle, the Company applies the following five steps: (a) identify contract(s) with a customer; (b) identify the performance obligations in a contract; (c) determine the transaction price; (d) allocate the transaction price to the performance obligations; and (e) recognize revenue when (or as) performance obligations are satisfied. The Company determines that performance obligations have been satisfied when its customers obtain control of the goods or services as evidenced by the customer’s ability to direct the use, or to receive substantially all of the remaining economic benefit, of the contract assets. Additionally, for purposes of determining the appropriate timing of recognition, revenue is recognized either over time or at a point in time based on an evaluation of the nature of and contractual terms relating to each performance obligation.
The determination that the core principle for revenue recognition has been met, and the five steps have been applied appropriately, requires significant judgment. Management considers the application of this judgment to be critical in determining the appropriate amount of revenue to be recognized. The most critical judgments include the determination of the transaction price,
the identification of the performance obligations, and the determination of the extent to which such performance obligations have been satisfied. A misapplication of this judgment could result in inappropriate recognition of revenue.
For the Company's recovery audit contracts, which represent approximately 97% of consolidated revenue for the year ended December 31, 2019, revenue is recognized over time on an invoice basis. Management believes that the Company's right to consideration from its customers corresponds directly to the value provided to customers from its performance to-date, as measured by billable recoveries. A recovery is billable when it is determined that the customer has received the economic benefit from the service (generally through credits taken against existing accounts payable due to, or refund checks received from, the customer’s vendors). The specific conditions upon which a recovery may be billed may vary from client to client and are negotiated as part of the contracting process.
Historically, a portion of the Company’s revenue is refunded back to customers, resulting from successful vendor challenges to billed recoveries, where our clients refund the vendor and we subsequently refund our clients for our related fees. The Company computes an estimate of future refunds, based on historical data, and maintains provisions for such refunds on its balance sheet as refund liabilities. The Company considers the refund liability to be variable consideration.
For the Company's subscription services, revenue is recognized ratably over time during the term of the subscription service. The subscription term commences when the customer both has access to the software application and can benefit from its use. Implementation services, hosting services, unspecified upgrades, technical and support services, service level guarantees and subscription rights under contracts for subscription services are typically delivered concurrently and are therefore treated as a single performance obligation.
The Company derives a relatively small portion of revenue on a fee-for-service basis whereby billings are based upon a fixed fee, a fee per unit of time, or a fee per other unit of service. The Company recognizes revenue for these types of services when the core principles for revenue recognition have been met. For services provided on a fixed fee basis revenue is either recognized over time or at a point in time, depending on the nature of the service and the contractual terms. For certain services performed on a fee per unit of time-basis, the Company applies the ‘as invoiced’ practical expedient described in Topic 606.
When a contract includes an option to acquire future goods or services that constitutes a material right to the customer, and those goods or services are similar to the original goods and services provided for in the contract, the Company has adopted the Practical Alternative as prescribed in ASC Topic 606 to estimate the standalone selling price of that option.
Billed receivables are stated at the amount expected to be collected and do not bear interest. The Company makes ongoing estimates relating to the collectability of billed receivables and maintains a reserve for estimated losses resulting from the inability of its clients to meet its financial obligations to the Company. This reserve is primarily based on the extent to which receivables are past due (based on contractual payment terms), the Company's history of write-offs, and the economic status of its clients.
Unbilled receivables relate to claims for which the Company's customers have received economic value and have acknowledged that the corresponding fees have been earned.
The Company includes both unbilled receivables and refund liabilities in determining revenue.
Contract liabilities are recorded when consideration is received and the Company has not yet transferred the goods or services to the customer. The Company refers to this as deferred revenue.
Contract Balances
As of December 31, 2019 and December 31, 2018, we had the following balances (in thousands) included in our Consolidated Balance Sheets that relate to contracts with our clients.
|
|
|
|
|
|
|
|
|
|
|
|
12/31/2019
|
12/31/2018
|
Change
|
Contract receivables from billed revenue
|
$
|
38,201
|
|
$
|
43,878
|
|
$
|
(5,677
|
)
|
Contract receivables from unbilled revenue
|
4,911
|
|
2,987
|
|
1,924
|
|
Deferred revenue
|
(2,217
|
)
|
(2,428
|
)
|
211
|
|
Refund liabilities
|
4,513
|
|
6,497
|
|
(1,984
|
)
|
During the twelve months ended December 31, 2019, we recognized $2.0 million of revenue related to the deferred revenue balance at December 31, 2018, as the result of performance obligations satisfied.
The decrease in our contract receivables balance from billed revenue at December 31, 2019 compared to December 31, 2018 is mainly due to four factors: lower revenue generated in the fourth quarter of fiscal year 2019 compared with the revenue generated in the fourth quarter of fiscal year 2018; higher cash collections in the fourth quarter of fiscal year 2019 compared with cash collected in the fourth quarter of fiscal year 2018; the settlement of Healthcare Claims Recovery Audit ("HCRA") services business obligations, including receivables, during fiscal year 2019; and an increase in allowance for bad debt as of December 31, 2019 compared to December 31, 2018.
The increase in our contract receivables balance from unbilled revenue at December 31, 2019 compared to December 31, 2018 is mainly due to an increase in the amount of unbilled revenue for a single client, where the Company issues invoices according to scheduled billing arrangements.
The decrease in our deferred revenue balance at December 31, 2019 compared to December 31, 2018 is mainly due to a year-over-year reduction in fees billed for services in our Recovery Audit segments.
The decrease in our refund liabilities balance at December 31, 2019 compared to December 31, 2018 is mainly due to the elimination of that portion of the refund liability attributable to our HCRA services business receivables arising from the final settlement of HCRA services business obligations.
Disaggregation of Revenue
We depict revenue earned by country and by reporting segment in our Operating Segments and Related Information disclosure. Refer to Note 2 of the Notes to our Consolidated Financial Statements for further information pertaining to our disaggregation of revenue.
Refund Liabilities
Refund liabilities result from reductions in the economic value previously received by our clients with respect to vendor claims identified by us and for which we previously have recognized revenue. We compute the estimate of our refund liabilities at any given time based on actual historical refund data. We record periodic changes in refund liabilities as adjustments to revenue. We satisfy such refund liabilities either by offsets to amounts otherwise due from clients or by cash refunds to clients.
On an on-going basis, we evaluate our estimates and judgments, including those related to refund liabilities. We base our estimates and judgments on historical experience, information available prior to the issuance of the consolidated financial statements and on various other factors that we believe to be reasonable under the circumstances. This information forms the basis for our judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Materially different results can occur as circumstances change and additional information becomes known, including changes in those estimates not deemed “critical."
(d) Cash and Cash Equivalents
Cash and cash equivalents include all cash balances and highly liquid investments with an initial maturity of three months or less from date of purchase. We place our temporary cash investments with high credit quality financial institutions. At times, certain investments may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limit or otherwise may not be covered by FDIC insurance. Some of our cash and cash equivalents are held at banks in jurisdictions outside the U.S. that have restrictions on transferring such assets outside of these countries on a temporary or permanent basis. Such restricted net assets are not significant in comparison to our consolidated net assets.
The $15.0 million in cash and cash equivalents as of December 31, 2019 includes $2.9 million held in the U.S., $1.5 million held in Canada, and $10.6 million held in other foreign jurisdictions, primarily in Australia, the United Kingdom and India. Our cash and cash equivalents included short-term investments of approximately $0.9 million as of December 31, 2019 and $1.4 million as of December 31, 2018, all of which were held at banks outside of the United States, primarily in Canada and Brazil.
(e) Fair Value of Financial Instruments
We state cash equivalents at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled receivables, accounts payable, deferred revenue and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short-term maturity of these items.
We record bank debt, if any, as of the period end date based on the effective borrowing rate and repayment terms when originated. As of December 31, 2019, we had $37.0 million in bank debt outstanding. As of December 31, 2018, we had $21.6 million in bank debt outstanding. We believe the carrying value of the bank debt approximates its fair value. We considered the factors used in determining the fair value of this debt to be Level 3 inputs (significant unobservable inputs).
We had $4.2 million of business acquisition obligations as of December 31, 2018. Our business acquisition obligations represent the fair value of deferred consideration and earnout payments estimated to be due as of the date for which we
recorded these amounts. We determine the preliminary estimated fair values based on our projections of future revenue and profits or other factors used in the calculation of the ultimate payment to be made. The discount rate that we use to value the liability is based on specific business risk, cost of capital, and other factors. We consider these factors to be Level 3 inputs (significant unobservable inputs). The earnout payment obligations associated with the business acquisition obligations were settled in 2019 and the balances were reduced to zero as of December 31, 2019.
We state certain assets at fair value on a nonrecurring basis as required by accounting principles generally accepted in the United States of America. Generally, these assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.
(f) Property and Equipment
We report property and equipment at cost or estimated fair value at acquisition date and depreciate them over their estimated useful lives using the straight-line method. Our useful lives for fixed assets are three years for computer laptops, four years for desktops, five years for IT server, storage and network equipment, five years for furniture and fixtures and three years for purchased software. We amortize leasehold improvements using the straight-line method over the shorter of the lease term or ten years. Depreciation expense from continuing operations was $10.0 million in 2019, $7.4 million in 2018 and $4.6 million in 2017.
We review the carrying value of property and equipment for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the carrying value, we will recognize an impairment loss equal to the amount by which the carrying value exceeds the fair value of the asset. No impairment charges were necessary in the three years ended December 31, 2019.
(g) Software Development Costs
We capitalize a portion of the costs we incur related to our internal development of software that we use in our operations and amortize these costs using the straight-line method over the expected useful lives of three to seven years.
We also capitalize a portion of the costs we incur related to our internal development of software that we intend to market to others. We amortize these costs over the products’ estimated economic lives, which typically are three years, beginning when the underlying products are available for general release to clients. We review the carrying value of capitalized software development costs for impairment whenever events and circumstances indicate that the carrying value of the asset may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the carrying value, we will recognize an impairment loss equal to the amount by which the carrying value exceeds the fair value of the asset. During the fourth quarter of 2019, as a result of this evaluation, it was determined that previously capitalized internally developed software was impaired and was no longer expected to provide future value. Accordingly, the Company recorded an impairment charge of $7.5 million in the fourth quarter of 2019. For additional information on impairment charges by segment, see Note 2—Operating Segments and Related Information.
We consider software development activities to be research and development costs and expense them as incurred. However, we capitalize the costs incurred for the development of computer software that will be sold, leased, or otherwise marketed or that will be used in our operations beginning when technological feasibility has been established. We consider the costs associated with developing or replacing methodologies to be development costs. Development costs were approximately $4.7 million in 2019, $8.3 million in 2018 and $1.2 million in 2017.
(h) Leases
The Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are generally those leases that allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property, equipment and software, net. All other leases are categorized as operating leases. The Company’s leases generally have terms that range from two to five years for equipment and two to ten years for real property.
Certain lease contracts include obligations to pay for other services, such as operations and maintenance. For leases of real property, the Company accounts for these other services as a component of the lease. For substantially all other leases, the services are accounted for separately and the Company allocates payments to the lease and other services components based on estimated stand-alone prices.
Lease liabilities are initially recognized at the present value of the fixed lease payments, reduced by landlord incentives using a discount rate based on similarly secured borrowings available to the Company. Lease assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives using a discount rate based on similarly secured borrowings available to the Company, plus any direct costs from executing the leases. Lease assets are tested for impairment in the same
manner as long-lived assets used in operations. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.
When the Company has the option to extend a lease term, terminate a lease before the contractual expiration date, or purchase a leased asset, and it is reasonably certain that the Company will exercise the option, the Company considers these options in determining the classification and measurement of such lease. The Company’s leases may include variable payments, primarily related to common area maintenance, insurance or taxes, which are expensed as incurred.
Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease. Finance lease assets are amortized within operating expenses on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease term. The interest component of a finance lease is included in interest expense and recognized using the effective interest method over the lease term.
(i) Goodwill and Intangible Assets
Goodwill represents the excess of the purchase price over the estimated fair value of net identifiable assets of acquired businesses. We evaluate the recoverability of goodwill and other intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other, in the fourth quarter of each year or sooner if events or changes in circumstances indicate that the carrying amount may exceed its fair value. In January 2017, the FASB issued ASU 2017-04, “Simplifying the Test for Goodwill Impairment” (“ASU 2017-04”). ASU 2017-04 eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an impairment charge is recorded based on the excess of a reporting unit’s carrying amount over its fair value, limited to the total amount of goodwill allocated to that reporting unit. As a result of changes in our go to market strategy, we applied ASU 2017-04 to determine the carrying value of the Adjacent Services reporting segment exceeded its fair value and goodwill was impaired. The Company recorded an impairment charge of $2.5 million in the fourth quarter of 2019. No impairment charges were necessary based on our internal calculations in the two years ended December 31, 2018.
(j) Direct Expenses and Deferred Costs
We typically expense direct expenses that we incur during the course of recovery audit and delivery of Adjacent Services offerings as incurred. For certain implementation and set-up costs associated with our “fee for service” revenue that we earn over an extended period of time, we defer the related direct and incremental costs and recognize them as expenses over the life of the underlying contract.
(k) Income Taxes
We account for income taxes under the asset and liability method. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. We measure deferred tax assets and liabilities using enacted tax rates we expect to apply to taxable income in the years in which we expect to recover or settle those temporary differences. We recognize the effect on the deferred tax assets and liabilities of a change in tax rates in income in the period that includes the enactment date.
We reduce our deferred tax assets by a valuation allowance if it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences are deductible. In determining the amount of valuation allowance to record, we consider all available positive and negative evidence affecting specific deferred tax assets, including our past and anticipated future performance, the reversal of deferred tax liabilities, the length of carry-back and carry-forward periods and the implementation of tax planning strategies. Objective positive evidence is necessary to support a conclusion that a valuation allowance is not needed for all or a portion of deferred tax assets when significant negative evidence exists. Cumulative losses in recent years are the most compelling form of negative evidence we considered in this determination.
We apply a “more-likely-than-not” recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. We refer to GAAP for guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. In accordance with FASB ASC 740, our policy for recording interest and penalties associated with tax positions is to record such items as a component of income before income taxes. A number of years may elapse before a particular tax position is audited and finally resolved or when a tax assessment is raised. The number of years subject to tax assessments also varies by tax jurisdictions.
(l) Foreign Currency
We use the local currency as the functional currency in the majority of the countries in which we conduct business outside of the United States. We translate the assets and liabilities denominated in foreign currencies into U.S. dollars at the current rates of exchange at the balance sheet date. We include the translation gains and losses as a separate component of shareholders’ equity
and in the determination of comprehensive income (loss). We translate revenue and expenses in foreign currencies at the weighted average exchange rates for the period. We separately state the foreign currency transaction gains and losses on short-term intercompany balances in the Consolidated Statements of Operations. We include all other realized and unrealized foreign currency transaction gains (losses) in “Selling, general and administrative expenses.”
(m) Earnings (Loss) Per Common Share
We compute basic earnings (loss) per common share by dividing net income (loss) available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. We compute diluted earnings (loss) per common share by dividing net income (loss) available to common shareholders by the sum of (1) the weighted-average number of shares of common stock outstanding during the period, (2) the dilutive effect of the assumed exercise of stock options using the treasury stock method, and (3) the dilutive effect of other potentially dilutive securities. We exclude the potential dilutive effect of stock options and convertible instruments from the determination of diluted earnings (loss) per common share if the effect of including them would be antidilutive.
(n) Stock-Based Compensation
We account for awards of equity instruments issued to employees and directors under the fair value method of accounting and recognize such amounts in our Consolidated Statements of Operations. We measure compensation expense for all time-based stock-based awards at fair value on the date of grant and recognize compensation expense, less actual forfeitures, in our Consolidated Statements of Operations using the straight-line method over the service period over which we expect the awards to vest. We recognize compensation expense for awards with performance conditions based on the probable outcome of the performance conditions. We accrue compensation expense if we believe it is probable that the performance condition(s) will be achieved and do not accrue compensation expense if we believe it is not probable that the performance condition(s) will be achieved. In the event that it becomes probable that performance condition(s) will no longer be achieved, we reverse all of the previously recognized compensation expense in the period such a determination is made.
We estimate the fair value of all time-vested options as of the date of grant using the Black-Scholes option valuation model, which was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Option valuation models require the input of subjective assumptions, including the expected stock price volatility, which we calculate based on the historical volatility of our common stock. We use a risk-free interest rate, based on the U.S. Treasury instruments in effect at the time of the grant, for the period comparable to the expected term of the option. We use the “simplified” method in estimating the expected term of options as we have concluded that our historical share option exercise experience is a less than reasonable basis upon which to estimate the expected term for our grants.
We estimate the fair value of nonvested stock awards (restricted stock and restricted stock units) as being equal to the market value of the common stock on the date of the award. We classify our share-based payments as either liability-classified awards or as equity-classified awards. We remeasure liability-classified awards to fair value at each balance sheet date until the award is settled. We measure equity-classified awards at their grant date fair value and do not subsequently remeasure them. We have classified our share-based payments which are settled in our common stock as equity-classified awards and our share-based payments that are settled in cash as liability-classified awards. Compensation expense related to equity-classified awards generally are equal to the fair value of the award at grant-date amortized over the vesting period of the award. The liability for liability-classified awards generally is equal to the fair value of the award as of the balance sheet date multiplied by the percentage vested at the time. We record the change in the liability amount from one balance sheet date to another to compensation expense.
(o) Comprehensive Income (Loss) and Accumulated Other Comprehensive Income
Consolidated comprehensive income (loss) consists of consolidated net income (loss) and foreign currency translation adjustments. We present the calculation of consolidated comprehensive income (loss) in the accompanying Consolidated Statements of Comprehensive Income (Loss). No amounts have been reclassified out of Accumulated Other Comprehensive Income during the periods presented in our consolidated financial statements.
(p) Segment Reporting
We report our operating segment information in three segments: Recovery Audit Services – Americas; Recovery Audit Services – Europe/Asia-Pacific and Adjacent Services. We include the unallocated portion of corporate selling, general and administrative expenses not specifically attributable to our three operating segments in Corporate Support. Our business segments reflect the internal reporting that our Chief Executive Officer, who is our chief operating decision maker, uses for the purpose of making decisions about allocating resources and assessing performance. Our management, including our Chief Executive Officer, uses what we internally refer to as “Adjusted EBITDA” as the primary measure of profit or loss for purposes of assessing the operating performance of all operating segments. We define Adjusted EBITDA as earnings from continuing operations before
interest, taxes, depreciation and amortization (“EBITDA”) as adjusted for unusual and other significant items that management views as distorting the operating results of the various segments from period to period.
EBITDA and Adjusted EBITDA are not financial measures determined in accordance with GAAP. Such non-GAAP financial measures do not measure the profit or loss of the reportable segments in accordance with GAAP. Given that we use Adjusted EBITDA as our primary measure of segment performance, GAAP rules on segment reporting require that we include this non-GAAP measure in our discussion of our operating segments. We also must reconcile Adjusted EBITDA to our operating results presented on a GAAP basis. We provide this reconciliation in Note 2 to these consolidated financial statements along with other information about our reportable segments. We do not intend the reconciling items to be, nor should they be, interpreted as non-recurring or extraordinary, or in any manner be deemed as adjustments made in accordance with GAAP. Because Adjusted EBITDA is not a financial measure determined in accordance with GAAP, it may not be comparable to other similarly titled measures of other companies.
(q) Loss Contingencies
Certain conditions may exist as of the date the financial statements are issued that may result in a loss to the Company, but which will only be determined and resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.
If the assessment of a contingency indicates that it is probable that a material loss is likely to occur and the amount of the liability can be estimated, then the estimated liability is accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.
Loss contingencies considered remote are generally not accrued or disclosed unless they involve guarantees, in which case the nature of the guarantee would be disclosed. Legal costs relating to loss contingencies are expensed as incurred.
(r) Impact of Recently Issued Accounting Standards
A summary of the recently issued accounting standards issued by the Financial Accounting Standards Board (“FASB”) and included in the Accounting Standards Codification (“ASC”) that apply to us is set forth below.
Adopted by the Company in Fiscal Year 2019
In February 2016, the FASB issued Accounting Standards Update ("ASU") 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements. ASU 2018-11 provides entities another option for transition when adopting ASU 2016-02, allowing entities to not apply the new standard in the comparative periods they present in their financial statements in the year of adoption.
The Company adopted the new standards effective January 1, 2019, using the modified retrospective approach provided by ASU 2018-11. The Company elected certain practical expedients permitted under the transition guidance, including the election to carry forward historical lease classifications. The Company also elected the short-term lease practical expedient, which allowed the Company to not recognize leases with a term of less than twelve months on our Consolidated Balance Sheets. In addition, the Company elected the lease and non-lease components practical expedient, for real property assets, which allowed us to calculate the present value of the fixed payments without performing an allocation of lease and non-lease components. Adoption of the new standard resulted in recording operating lease right-of-use assets and operating lease liabilities of approximately $15.9 million, with no material cumulative effect adjustment to retained earnings as of the date of adoption. The adoption of this standard did not have a material impact on our condensed Consolidated Statements of Operations or cash flows.
Operating leases are included in Operating lease right-of-use assets, Current portion of operating lease liabilities and Long-term operating lease liabilities on the Company's Consolidated Balance Sheet.
Accounting Standards Not Yet Adopted
FASB ASU 2016-13 - In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires entities to record expected credit losses for certain financial instruments, including trade receivables, as an allowance that reflects the entity's current estimate of credit losses expected to be incurred. ASU 2016-13 is effective for annual periods beginning after December 15, 2022, including interim
periods within those annual periods, and early adoption is permitted. The Company currently is evaluating the effect that the adoption of this standard will have on the Company's condensed consolidated financial statements.
FASB ASU 2018-13 - In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement, which modifies the disclosure requirements on fair value measurements. The new guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Upon the effective date, certain provisions are to be applied prospectively, while others are to be applied retrospectively to all periods presented. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this ASU and delay adoption of the additional disclosures until their effective date. The Company is evaluating the impact of the new standard on its consolidated financial statements, but does not anticipate the standard will have a significant impact.
FASB ASU 2018-15 - In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company adopted the standard on January 1, 2020, and has elected to apply the guidance prospectively to all implementation costs incurred after that date. The Company does not anticipate the standard will have a significant impact on its consolidated financial statements.
FASB ASU 2019-12 - In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies accounting for income taxes, changes the accounting for certain income tax transactions and makes certain improvements to the codification. These amendments will be effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the new standard to determine the impact it will have on the Company’s consolidated financial statements.
(2) OPERATING SEGMENTS AND RELATED INFORMATION
We conduct our operations through three reportable segments:
Recovery Audit Services – Americas represents recovery audit services (other than HCRA services) provided in the United States of America (“U.S.”), Canada and Latin America.
Recovery Audit Services – Europe/Asia-Pacific represents recovery audit services provided in Europe, Asia and the Pacific region.
Adjacent Services represents data transformation, spend analytics and associated advisory services.
We include the unallocated portion of corporate selling, general and administrative expenses not specifically attributable to the three reportable segments in Corporate Support.
Discontinued Operations - In the fourth quarter of 2015, PRGX entered into agreements with third parties to fulfill its Medicare recovery audit contractor ("RAC") program subcontract obligations to audit Medicare payments and provide support for claims appeals and assigned its remaining Medicaid contract to another party. The Company has entered into settlement agreements with two of the three Medicare RAC-related third-parties. The Company believes the likelihood of further claims related to the final Medicare RAC contract is remote. As a result, the associated liability and receivable balances that relate to the final contract were reduced to zero in the third quarter of 2019. The HCRA services business is reported as Discontinued Operations in accordance with GAAP.
Discontinued operations information for the years ended December 31, 2019, 2018 and 2017 (in thousands) is as follows:
|
|
|
|
|
|
|
|
|
|
|
Results of Discontinued Operations
(in thousands)
|
Years Ended December 31,
|
|
2019
|
2018
|
2017
|
Revenue, net
|
$
|
—
|
|
$
|
959
|
|
$
|
—
|
|
Cost of sales (adjustments)
|
(616
|
)
|
(300
|
)
|
1,350
|
|
Selling, general and administrative expense
|
8
|
|
16
|
|
14
|
|
Depreciation of property, equipment and software assets
|
—
|
|
1
|
|
8
|
|
Pretax income (loss) from discontinued operations before income taxes
|
608
|
|
1,242
|
|
(1,372
|
)
|
Income tax expense
|
—
|
|
—
|
|
—
|
|
Net income (loss) from discontinued operations
|
$
|
608
|
|
$
|
1,242
|
|
$
|
(1,372
|
)
|
The following table presents the discontinued operations of the HCRA services business in the Consolidated Statements of Cash Flows, for the years ended December 31 2019, 2018 and 2017 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
2019
|
|
2018
|
|
2017
|
Net cash used in operating activities
|
$
|
(181
|
)
|
|
$
|
(1,484
|
)
|
|
$
|
(1,364
|
)
|
Net cash used in investing activities
|
—
|
|
|
—
|
|
|
—
|
|
Net cash provided by financing activities
|
—
|
|
|
—
|
|
|
—
|
|
Increase (decrease) in cash and cash equivalents
|
$
|
(181
|
)
|
|
$
|
(1,484
|
)
|
|
$
|
(1,364
|
)
|
We evaluate the performance of our reportable segments based upon revenue and measures of profit or loss we refer to as EBITDA and Adjusted EBITDA. We define Adjusted EBITDA as earnings before interest and taxes (“EBIT”), adjusted for depreciation and amortization (“EBITDA”), and then further adjusted for unusual and other significant items that management views as distorting the operating results of the various segments from period to period. Such adjustments include restructuring charges, stock-based compensation, bargain purchase gains, acquisition-related charges and benefits (acquisition transaction costs, acquisition obligations classified as compensation, and fair value adjustments to acquisition-related contingent consideration), tangible and intangible asset impairment charges, certain litigation costs and litigation settlements, transformation, severance charges and foreign currency transaction gains and losses on short-term intercompany balances viewed by management as individually or collectively significant. We do not have any inter-segment revenue.
Segment information for the years ended December 31, 2019, 2018 and 2017 (in thousands) is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recovery
Audit
Services –
Americas
|
|
Recovery Audit
Services –
Europe/Asia-
Pacific
|
|
Adjacent
Services
|
|
Corporate
Support
|
|
Total
|
2019
|
|
|
|
|
|
|
|
|
|
|
Revenue, net
|
|
$
|
116,708
|
|
|
$
|
47,283
|
|
|
$
|
5,767
|
|
|
$
|
—
|
|
|
$
|
169,758
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss from continuing operations
|
|
|
|
|
|
|
|
|
|
$
|
(14,328
|
)
|
Income tax expense
|
|
|
|
|
|
|
|
|
|
930
|
|
Interest expense, net
|
|
|
|
|
|
|
|
|
|
1,817
|
|
EBIT
|
|
$
|
27,118
|
|
|
$
|
10,440
|
|
|
$
|
(9,142
|
)
|
|
$
|
(39,997
|
)
|
|
(11,581
|
)
|
Depreciation of property, equipment and software assets
|
|
8,184
|
|
|
706
|
|
|
1,091
|
|
|
—
|
|
|
9,981
|
|
Amortization of intangible assets
|
|
1,750
|
|
|
169
|
|
|
1,546
|
|
|
—
|
|
|
3,465
|
|
EBITDA
|
|
37,052
|
|
|
11,315
|
|
|
(6,505
|
)
|
|
(39,997
|
)
|
|
1,865
|
|
Impairment charges
|
|
1,497
|
|
|
$
|
24
|
|
|
3,425
|
|
|
5,127
|
|
|
10,073
|
|
Foreign currency transaction losses (gains) on short-term intercompany balances
|
|
(208
|
)
|
|
716
|
|
|
4
|
|
|
(214
|
)
|
|
298
|
|
Acquisition-related adjustments (income) loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(250
|
)
|
|
(250
|
)
|
Transformation and severance expenses
|
|
1,874
|
|
|
667
|
|
|
861
|
|
|
1,755
|
|
|
5,157
|
|
Other (income) loss
|
|
2
|
|
|
10
|
|
|
2
|
|
|
(17
|
)
|
|
(3
|
)
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,930
|
|
|
4,930
|
|
Adjusted EBITDA
|
|
$
|
40,217
|
|
|
$
|
12,732
|
|
|
$
|
(2,213
|
)
|
|
$
|
(28,666
|
)
|
|
$
|
22,070
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
$
|
1,253
|
|
|
$
|
640
|
|
|
$
|
66
|
|
|
$
|
13,068
|
|
|
$
|
15,027
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocated assets
|
|
$
|
78,476
|
|
|
$
|
26,429
|
|
|
$
|
1,331
|
|
|
$
|
—
|
|
|
$
|
106,236
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated assets:
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,982
|
|
|
14,982
|
|
Restricted cash
|
|
—
|
|
|
—
|
|
|
—
|
|
|
46
|
|
|
46
|
|
Deferred income taxes
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,921
|
|
|
3,921
|
|
Prepaid expenses and other assets
|
|
—
|
|
|
—
|
|
|
—
|
|
|
281
|
|
|
281
|
|
Total assets
|
|
$
|
78,476
|
|
|
$
|
26,429
|
|
|
$
|
1,331
|
|
|
$
|
19,230
|
|
|
$
|
125,466
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recovery
Audit
Services –
Americas
|
|
Recovery Audit
Services –
Europe/Asia-
Pacific
|
|
Adjacent
Services
|
|
Corporate
Support
|
|
Total
|
2018
|
|
|
|
|
|
|
|
|
|
|
Revenue, net
|
|
$
|
115,920
|
|
|
$
|
49,526
|
|
|
$
|
6,330
|
|
|
$
|
—
|
|
|
$
|
171,776
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations
|
|
|
|
|
|
|
|
|
|
$
|
3,351
|
|
Income tax expense
|
|
|
|
|
|
|
|
|
|
1,321
|
|
Interest expense, net
|
|
|
|
|
|
|
|
|
|
1,663
|
|
EBIT
|
|
$
|
26,602
|
|
|
$
|
12,413
|
|
|
$
|
(5,231
|
)
|
|
$
|
(27,449
|
)
|
|
6,335
|
|
Depreciation of property, equipment and software assets
|
|
5,545
|
|
|
683
|
|
|
1,142
|
|
|
—
|
|
|
7,370
|
|
Amortization of intangible assets
|
|
1,664
|
|
|
172
|
|
|
1,559
|
|
|
—
|
|
|
3,395
|
|
EBITDA
|
|
33,811
|
|
|
13,268
|
|
|
(2,530
|
)
|
|
(27,449
|
)
|
|
17,100
|
|
Foreign currency transaction losses (gains) on short-term intercompany balances
|
|
367
|
|
|
1,044
|
|
|
14
|
|
|
(423
|
)
|
|
1,002
|
|
Acquisition-related adjustments (income) loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,628
|
)
|
|
(1,628
|
)
|
Transformation and severance expenses
|
|
944
|
|
|
1,194
|
|
|
66
|
|
|
918
|
|
|
3,122
|
|
Other (income) loss
|
|
(4
|
)
|
|
8
|
|
|
—
|
|
|
17
|
|
|
21
|
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,056
|
|
|
5,056
|
|
Adjusted EBITDA
|
|
$
|
35,118
|
|
|
$
|
15,514
|
|
|
$
|
(2,450
|
)
|
|
$
|
(23,509
|
)
|
|
$
|
24,673
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
$
|
2,050
|
|
|
$
|
1,200
|
|
|
$
|
257
|
|
|
$
|
6,891
|
|
|
$
|
10,398
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocated assets
|
|
$
|
71,211
|
|
|
$
|
26,147
|
|
|
$
|
7,294
|
|
|
$
|
—
|
|
|
$
|
104,652
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated assets:
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,973
|
|
|
13,973
|
|
Restricted cash
|
|
—
|
|
|
—
|
|
|
—
|
|
|
46
|
|
|
46
|
|
Deferred income taxes
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,561
|
|
|
3,561
|
|
Prepaid expenses and other assets
|
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
910
|
|
|
910
|
|
Discontinued operations
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,687
|
|
|
1,687
|
|
Total assets
|
|
$
|
71,211
|
|
|
$
|
26,147
|
|
|
$
|
7,294
|
|
|
$
|
20,177
|
|
|
$
|
124,829
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recovery
Audit
Services –
Americas
|
|
Recovery Audit
Services –
Europe/Asia-
Pacific
|
|
Adjacent
Services
|
|
Corporate
Support
|
|
Total
|
2017
|
|
|
|
|
|
|
|
|
|
|
Revenue, net
|
|
$
|
113,122
|
|
|
$
|
44,372
|
|
|
$
|
4,126
|
|
|
$
|
—
|
|
|
$
|
161,620
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations
|
|
|
|
|
|
|
|
|
|
$
|
4,556
|
|
Income tax expense
|
|
|
|
|
|
|
|
|
|
2,962
|
|
Interest income, net
|
|
|
|
|
|
|
|
|
|
1,539
|
|
EBIT
|
|
$
|
29,163
|
|
|
$
|
11,700
|
|
|
$
|
(7,942
|
)
|
|
$
|
(23,864
|
)
|
|
9,057
|
|
Depreciation of property, equipment and software assets
|
|
3,165
|
|
|
599
|
|
|
805
|
|
|
—
|
|
|
4,569
|
|
Amortization of intangible assets
|
|
1,919
|
|
|
142
|
|
|
1,573
|
|
|
—
|
|
|
3,634
|
|
EBITDA
|
|
34,247
|
|
|
12,441
|
|
|
(5,564
|
)
|
|
(23,864
|
)
|
|
17,260
|
|
Foreign currency transaction gains on short-term intercompany balances
|
|
(249
|
)
|
|
(1,769
|
)
|
|
(9
|
)
|
|
(163
|
)
|
|
(2,190
|
)
|
Acquisition-related adjustments (income)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,283
|
)
|
|
(2,283
|
)
|
Transformation and severance expenses
|
|
313
|
|
|
655
|
|
|
320
|
|
|
378
|
|
|
1,666
|
|
Other loss (income)
|
|
751
|
|
|
184
|
|
|
(195
|
)
|
|
(900
|
)
|
|
(160
|
)
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,052
|
|
|
7,052
|
|
Adjusted EBITDA
|
|
$
|
35,062
|
|
|
$
|
11,511
|
|
|
$
|
(5,448
|
)
|
|
$
|
(19,780
|
)
|
|
$
|
21,345
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
$
|
2,389
|
|
|
$
|
2,383
|
|
|
$
|
1,335
|
|
|
$
|
3,248
|
|
|
$
|
9,355
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocated assets
|
|
$
|
65,397
|
|
|
$
|
22,474
|
|
|
$
|
9,486
|
|
|
$
|
—
|
|
|
$
|
97,357
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated assets:
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
—
|
|
|
18,823
|
|
|
18,823
|
|
Restricted cash
|
|
—
|
|
|
—
|
|
|
—
|
|
|
51
|
|
|
51
|
|
Deferred income taxes
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,538
|
|
|
1,538
|
|
Prepaid expenses and other assets
|
|
—
|
|
|
—
|
|
|
—
|
|
|
910
|
|
|
910
|
|
Discontinued operations
|
|
|
|
|
|
|
|
1,539
|
|
|
1,539
|
|
Total assets
|
|
$
|
65,397
|
|
|
$
|
22,474
|
|
|
$
|
9,486
|
|
|
$
|
22,861
|
|
|
$
|
120,218
|
|
The following table presents revenue by country based on the location of clients served (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2019
|
|
2018
|
|
2017
|
United States
|
|
$
|
101,806
|
|
|
$
|
100,458
|
|
|
$
|
93,447
|
|
United Kingdom
|
|
25,864
|
|
|
27,774
|
|
|
23,408
|
|
Canada
|
|
12,592
|
|
|
14,700
|
|
|
14,375
|
|
Australia
|
|
9,169
|
|
|
8,397
|
|
|
8,732
|
|
France
|
|
6,853
|
|
|
6,721
|
|
|
5,987
|
|
Mexico
|
|
3,789
|
|
|
3,793
|
|
|
5,385
|
|
Brazil
|
|
1,795
|
|
|
1,799
|
|
|
2,053
|
|
Thailand
|
|
1,523
|
|
|
1,094
|
|
|
699
|
|
Spain
|
|
1,315
|
|
|
1,443
|
|
|
1,127
|
|
Hong Kong
|
|
1,280
|
|
|
1,219
|
|
|
889
|
|
Ireland
|
|
522
|
|
|
741
|
|
|
929
|
|
New Zealand
|
|
417
|
|
|
338
|
|
|
899
|
|
Colombia
|
|
306
|
|
|
465
|
|
|
709
|
|
Other
|
|
2,527
|
|
|
2,834
|
|
|
2,981
|
|
|
|
$
|
169,758
|
|
|
$
|
171,776
|
|
|
$
|
161,620
|
|
The following table presents long-lived assets by country based on the location of the asset (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
2019
|
|
2018
|
United States
|
|
$
|
28,493
|
|
|
$
|
34,236
|
|
UK
|
|
2,806
|
|
|
2,909
|
|
All Other
|
|
398
|
|
|
395
|
|
|
|
$
|
31,697
|
|
|
$
|
37,540
|
|
One client, The Kroger Co., accounted for approximately 10% of revenue from continuing operations in 2019, and approximately 12% of revenue from continuing operations in 2018 and 2017.
(3) (LOSS) EARNINGS PER COMMON SHARE
The following tables set forth the computations of basic and diluted (loss) earnings per common share (in thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
Basic (loss) earnings per common share:
|
|
2019
|
|
2018
|
|
2017
|
Numerator:
|
|
|
|
|
|
|
Net (loss) income from continuing operations
|
|
$
|
(14,328
|
)
|
|
$
|
3,351
|
|
|
$
|
4,556
|
|
Net income (loss) from discontinued operations
|
|
$
|
608
|
|
|
$
|
1,242
|
|
|
$
|
(1,372
|
)
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
Weighted-average common shares outstanding
|
|
22,651
|
|
|
22,811
|
|
|
21,937
|
|
|
|
|
|
|
|
|
Basic (loss) earnings per common share from continuing operations
|
|
$
|
(0.63
|
)
|
|
$
|
0.14
|
|
|
$
|
0.21
|
|
Basic earnings (loss) per common share from discontinued operations
|
|
$
|
0.03
|
|
|
$
|
0.06
|
|
|
$
|
(0.06
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
Diluted (loss) earnings per common share:
|
|
2019
|
|
2018
|
|
2017
|
Numerator:
|
|
|
|
|
|
|
Net (loss) income from continuing operations
|
|
$
|
(14,328
|
)
|
|
$
|
3,351
|
|
|
$
|
4,556
|
|
Net income (loss) from discontinued operations
|
|
$
|
608
|
|
|
$
|
1,242
|
|
|
$
|
(1,372
|
)
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
Weighted-average common shares outstanding
|
|
22,651
|
|
|
22,811
|
|
|
21,937
|
|
Effect of dilutive securities from stock-based compensation plans
|
|
—
|
|
|
623
|
|
|
174
|
|
Denominator for diluted (loss) earnings per common share
|
|
22,651
|
|
|
23,434
|
|
|
22,111
|
|
|
|
|
|
|
|
|
Diluted (loss) earnings per common share from continuing operations
|
|
$
|
(0.63
|
)
|
|
$
|
0.14
|
|
|
$
|
0.21
|
|
Diluted earnings (loss) per common share from discontinued operations
|
|
$
|
0.03
|
|
|
$
|
0.06
|
|
|
$
|
(0.06
|
)
|
Weighted-average shares outstanding excludes antidilutive securities that totaled 4.7 million, 0.9 million, and 2.3 million shares, respectively, from the computation of diluted earnings per common share for the years ended December 31, 2019, 2018, and 2017.
(4) GOODWILL AND INTANGIBLE ASSETS
(a) Goodwill
The Company evaluates the recoverability of goodwill annually in the fourth quarter of each year or sooner if events or changes in circumstances indicate that the carrying amount may exceed its fair value.
During the fourth quarter of 2019, the Company, working with independent valuation advisors, performed its annual impairment test using data as of October 1, 2019. For the test, the Company previously adopted FASB's ASC Update No. 2017-04 Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an impairment charge is recorded based on the excess of a reporting unit’s carrying amount over its fair value, limited to the total amount of goodwill allocated to that reporting unit.
The fair value of the reporting units were determined using the discounted cash flow method of the income approach and the guideline public company method of the market approach. The income approach used management's projections of estimated operating results and expected growth rates, and guideline public company methods to determine an invested capital value for each reporting unit. The fair value of invested capital (equity plus debt) was then compared to the book value of invested capital to determine if goodwill was impaired.
Based on the results of the annual impairment test, management determined the carrying value of the Adjacent Services reporting segment exceeded its fair value and goodwill was impaired. The Company recognized an impairment charge of $2.5 million. The majority of the goodwill impairment charge in the Adjacent Services reporting segment was recognized as a result of the Lavante acquisition.
Goodwill by reportable segments during 2019 and 2018 was as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recovery
Audit
Services –
Americas
|
|
Recovery Audit
Services –
Europe/Asia-
Pacific
|
|
Adjacent
Services
|
|
Total
|
Balance, January 1, 2018
|
|
$
|
13,440
|
|
|
$
|
1,680
|
|
|
$
|
2,528
|
|
|
$
|
17,648
|
|
Goodwill recorded in connection with business combinations
|
|
(20
|
)
|
|
—
|
|
|
—
|
|
|
(20
|
)
|
Foreign currency translation
|
|
—
|
|
|
(97
|
)
|
|
—
|
|
|
(97
|
)
|
Balance, December 31, 2018
|
|
13,420
|
|
|
1,583
|
|
|
2,528
|
|
|
17,531
|
|
Impairment (1)
|
|
—
|
|
|
—
|
|
|
(2,528
|
)
|
|
(2,528
|
)
|
Foreign currency translation
|
|
—
|
|
|
67
|
|
|
—
|
|
|
67
|
|
Balance, December 31, 2019
|
|
$
|
13,420
|
|
|
$
|
1,650
|
|
|
$
|
—
|
|
|
$
|
15,070
|
|
(1) Impairment represents the full impairment of goodwill in the Adjacent Services reporting segment recognized during the fourth quarter of 2019.
(b) Intangible Assets
Intangible assets consist principally of amounts we have assigned to customer relationships, trademarks, non-compete agreements and trade names in conjunction with business acquisitions. Certain of our intangible assets associated with acquisitions of assets or businesses by our foreign subsidiaries are denominated in the local currency of such subsidiary and therefore are subject to foreign currency ("FX") adjustments. We present the amounts for these transactions in United States dollars utilizing foreign currency exchange rates as of the respective balance sheet dates.
Amortization expense relating to intangible assets was $3.5 million in 2019, $3.4 million in 2018 and $3.6 million in 2017. As of December 31, 2019 and based on our current amortization methods and current levels of intangible assets, we project amortization expense relating to intangible assets for the next five years will be $3.1 million in 2020, $1.7 million in 2021, $0.7 million in 2022, $0.7 million in 2023 and $0.7 million in 2024. We use accelerated amortization methods for customer relationships and trade names, and straight-line amortization for non-compete agreements and trademarks.
Changes in noncurrent intangible assets during 2019 and 2018 were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer
Relationships
|
|
Trademarks
|
|
Non-
compete
Agreements
|
|
Software
|
|
Trade
Names
|
|
Total
|
Gross carrying amount:
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2018
|
|
$
|
46,906
|
|
|
$
|
1,026
|
|
|
$
|
2,629
|
|
|
$
|
6,178
|
|
|
$
|
2,200
|
|
|
$
|
58,939
|
|
FX adjustments and other
|
|
(547
|
)
|
|
138
|
|
|
(51
|
)
|
|
(164
|
)
|
|
—
|
|
|
(624
|
)
|
Balance, December 31, 2018
|
|
46,359
|
|
|
1,164
|
|
|
2,578
|
|
|
6,014
|
|
|
2,200
|
|
|
58,315
|
|
FX adjustments and other
|
|
372
|
|
|
(118
|
)
|
|
34
|
|
|
—
|
|
|
—
|
|
|
288
|
|
Balance, December 31, 2019
|
|
$
|
46,731
|
|
|
$
|
1,046
|
|
|
$
|
2,612
|
|
|
$
|
6,014
|
|
|
$
|
2,200
|
|
|
$
|
58,603
|
|
Accumulated amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2018
|
|
$
|
(33,862
|
)
|
|
$
|
(913
|
)
|
|
$
|
(1,602
|
)
|
|
$
|
(1,884
|
)
|
|
$
|
(2,200
|
)
|
|
$
|
(40,461
|
)
|
Amortization expense
|
|
(1,607
|
)
|
|
(67
|
)
|
|
(246
|
)
|
|
(1,475
|
)
|
|
—
|
|
|
(3,395
|
)
|
FX adjustments and other
|
|
409
|
|
|
(22
|
)
|
|
51
|
|
|
48
|
|
|
—
|
|
|
486
|
|
Balance, December 31, 2018
|
|
(35,060
|
)
|
|
(1,002
|
)
|
|
(1,797
|
)
|
|
(3,311
|
)
|
|
(2,200
|
)
|
|
(43,370
|
)
|
Amortization expense
|
|
(1,676
|
)
|
|
(68
|
)
|
|
(246
|
)
|
|
(1,475
|
)
|
|
—
|
|
|
(3,465
|
)
|
FX adjustments and other
|
|
(287
|
)
|
|
59
|
|
|
(34
|
)
|
|
—
|
|
|
—
|
|
|
(262
|
)
|
Balance, December 31, 2019
|
|
$
|
(37,023
|
)
|
|
$
|
(1,011
|
)
|
|
$
|
(2,077
|
)
|
|
$
|
(4,786
|
)
|
|
$
|
(2,200
|
)
|
|
$
|
(47,097
|
)
|
Net carrying amount:
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2018
|
|
$
|
11,299
|
|
|
$
|
162
|
|
|
$
|
781
|
|
|
$
|
2,703
|
|
|
$
|
—
|
|
|
$
|
14,945
|
|
Balance, December 31, 2019
|
|
$
|
9,708
|
|
|
$
|
35
|
|
|
$
|
535
|
|
|
$
|
1,228
|
|
|
$
|
—
|
|
|
$
|
11,506
|
|
Estimated useful life (years)
|
|
10-15 years
|
|
|
4-5 years
|
|
|
5 years
|
|
|
4 years
|
|
|
4-5 years
|
|
|
|
(5) DEBT
Debt issuance costs on the balance sheet are presented as a direct deduction from the related debt liability, rather than represented as a separate asset. Long-term debt as of December 31, 2019 and 2018 consists of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
As of
December 31, 2019
|
As of
December 31, 2018
|
Credit facility(1)
|
$
|
37,000
|
|
|
$
|
21,600
|
|
DFC (2)
|
(397
|
)
|
|
(65
|
)
|
Net credit facility
|
36,603
|
|
|
21,535
|
|
Finance lease obligations(1)
|
17
|
|
|
66
|
|
Total debt
|
36,620
|
|
|
21,601
|
|
Less: Current portion of long-term debt
|
17
|
|
|
48
|
|
Long-term debt, excluding current portion
|
$
|
36,603
|
|
|
$
|
21,553
|
|
|
|
(1)
|
Principal portion of long-term debt. Refer to Future Commitments table below for principal payments to be made on long-term debt.
|
|
|
(2)
|
DFC refers to deferred financing costs related to the Company's long-term debt.
|
Bank of America Credit Facility
On March 14, 2019, the Company, as co-borrower with PRGX USA, Inc. (“PRGX-USA”), a wholly-owned subsidiary that is the Company’s principal domestic operating subsidiary, entered into a five-year Credit Agreement (the “BOA Credit Facility”) with Bank of America, N.A. (“BOA”), and Synovus Bank as the initial lenders thereunder, and with BOA as the letter-of-credit issuer thereunder, as the swingline lender thereunder, and as the administrative agent (the “Administrative Agent”) for the lenders from time to time party thereto. The BOA Credit Facility consists of a $60.0 million senior revolving credit facility (the “Revolver”),
with a $5.0 million subfacility for the issuance of letters of credit, and a $5.0 million swingline loan subfacility (the “Swingline Loan”). The BOA Credit Facility is guaranteed by each of PRGX’s direct and indirect domestic wholly-owned subsidiaries (other than PRGX-USA), except for certain immaterial domestic subsidiaries. None of PRGX’s direct or indirect foreign subsidiaries have guaranteed the BOA Credit Facility. The BOA Credit Facility is secured by substantially all of the assets of PRGX, PRGX-USA and each guarantor (including the equity interests in substantially all of the Company’s domestic subsidiaries and up to sixty-five percent (65%) of the equity interests of certain of the Company’s first-tier material foreign subsidiaries).
In connection with the closing of the BOA Credit Facility, PRGX borrowed $30.0 million under the Revolver, substantially all of which was used to prepay in full the approximately $29.0 million in outstanding indebtedness owed to the lenders under PRGX’s pre-existing Amended & Restated Revolving Credit Agreement, dated December 23, 2014, as amended from time to time, by and among PRGX, PRGX-USA, the several banks and other financial institutions and lenders from time to time party thereto and SunTrust Bank, in its capacity as administrative agent for the lenders (the "SunTrust Credit Facility"), and to terminate that prior credit facility in its entirety. There were no early termination penalties associated with the termination of the SunTrust Credit Facility.
The BOA Credit Facility will mature on March 14, 2024. Interest is payable quarterly in arrears. There are no prepayment penalties in the event the Company elects to prepay and terminate the BOA Credit Facility prior to its scheduled maturity date, subject to breakage and redeployment costs in certain limited circumstances.
The Revolver bears interest at a rate per annum comprised of a specified index rate based on LIBOR plus an applicable interest rate margin determined under the BOA Credit Facility. For U.S. Dollar-denominated loans under the Revolver, at the option of the Borrowers, such loans shall bear interest at a rate per annum equal to (x) the LIBOR daily floating rate plus an applicable interest rate margin determined under the BOA Credit Facility or (y) the base rate plus the applicable interest rate margin, each as determined under the BOA Credit Facility. Although the Company does not anticipate the need for Swingline Loans, were any Swingline Loans to be made they would bear interest at the base rate plus the applicable interest rate margin for base rate loans, each as determined under the BOA Credit Facility. The applicable interest rate margin varies from 1.50% per annum to 2.25% per annum, for LIBOR daily floating rate loans, and from 0.50% per annum to 1.25% per annum, for loans based on the base rate, and in either case depending on the Company’s consolidated leverage ratio, and is determined in accordance with a pricing grid under the BOA Credit Facility.
The BOA Credit Facility includes customary affirmative, negative, and financial covenants binding on the Company, including delivery of financial statements and other reports and maintenance of existence. The negative covenants limit the ability of the Company, among other things, to incur debt, incur liens, make investments and sell assets, but does provide for certain permitted repurchases of shares of its capital stock and the declaration and payment of certain dividends on its capital stock. The financial covenants included in the BOA Credit Facility set forth a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio for the Company, each which will be tested on a quarterly basis; and with the Company having the ability to increase the maximum leverage ratio for a limited time when needed in connection with permitted acquisitions. In addition, the BOA Credit Facility includes customary events of default.
As of December 31, 2019, there was $37.0 million in debt outstanding under the BOA Credit Facility that will be due March 14, 2024. The amount available for additional borrowing under the BOA Credit Facility was $23.0 million as of December 31, 2019. Based on the terms of the BOA Credit Facility, on December 31, 2019 the applicable interest rate (inclusive of the applicable interest rate margin) for LIBOR daily floating rate loans (the only type outstanding on December 31, 2019) was approximately 3.55%. As of December 31, 2019, the Company was required to pay a commitment fee of 0.25% per annum, payable quarterly, on the unused portion of the BOA Credit Facility.
Future Commitments
The following is a summary of the combined principal maturities of all long-term debt and principal payments to be made under the Company’s capital lease agreements for each of the fiscal years presented in the table below (in thousands):
|
|
|
|
|
|
Year Ended December 31
|
|
|
2020
|
|
$
|
17
|
|
2021
|
|
—
|
|
2022
|
|
—
|
|
2023
|
|
—
|
|
2024
|
|
37,000
|
|
Total
|
|
$
|
37,017
|
|
(6) LEASES
The Company primarily leases office space and certain office equipment using noncancelable operating leases. Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the implicit rate is not readily determinable in most of the Company's lease agreements, the Company uses its estimated secured incremental borrowing rate, which takes into consideration the relevant term of the underlying lease, in determining the present value of lease payments. Lease expense is recognized on a straight-line basis over the lease terms. Certain of our lease agreements include variable lease payments, primarily related to common area maintenance, insurance and taxes. The variable portion of payments is not included in the initial measurement of the right-of-use asset or lease liability due to the uncertainty of the payment amount and are recorded as lease expense in the period incurred.
The Company's leases have original lease periods expiring between 2020 and 2027, which may include the option to extend the lease when it is reasonably certain the Company will exercise that option. The Company does not have lease agreements with residual value guarantees, sale leaseback terms or material restrictive covenants.
The components of lease expense, lease term and discount rate are as follows (in thousands):
|
|
|
|
|
|
|
|
Year Ended
December 31, 2019
|
Operating lease cost
|
|
$
|
4,820
|
|
Short-term lease cost
|
|
88
|
|
Variable lease cost
|
|
841
|
|
Sublease income
|
|
(73
|
)
|
Total lease cost
|
|
$
|
5,676
|
|
Rent expense was $4.9 million in 2018 and $5.1 million in 2017.
As of December 31, 2019, the weighted average remaining lease term and weighted average discount rate for the Company's operating leases were as follows:
|
|
|
|
|
|
|
Operating Leases
|
Weighted Average Remaining Lease Term
|
|
3.5 years
|
|
Weighted Average Discount Rate
|
|
4.1
|
%
|
The following is a schedule, by years, of maturities of lease liabilities as of December 31, 2019 (in thousands):
|
|
|
|
|
|
|
|
Operating Leases
|
2020
|
|
$
|
4,165
|
|
2021
|
|
3,866
|
|
2022
|
|
1,818
|
|
2023
|
|
1,134
|
|
2024
|
|
707
|
|
Thereafter
|
|
345
|
|
Total undiscounted cash flows
|
|
12,035
|
|
Less imputed interest
|
|
(883
|
)
|
Present value of lease liabilities
|
|
$
|
11,152
|
|
Supplemental cash flow information related to the Company's operating leases are as follows (in thousands):
|
|
|
|
|
|
Year Ended
December 31, 2019
|
Non-cash activity:
|
|
Right-of-use assets obtained in exchange for operating lease obligations
|
$
|
15,929
|
|
Operating cash flows:
|
|
Cash paid for amounts included in the measurement of lease liabilities
|
$
|
4,860
|
|
(7) INCOME TAXES
(Loss) income before income taxes from continuing operations relate to the following jurisdictions (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2019
|
|
2018
|
|
2017
|
United States
|
|
$
|
(18,027
|
)
|
|
$
|
(4,673
|
)
|
|
$
|
(6,502
|
)
|
Foreign
|
|
4,629
|
|
|
9,345
|
|
|
14,020
|
|
|
|
$
|
(13,398
|
)
|
|
$
|
4,672
|
|
|
$
|
7,518
|
|
The provision for income taxes for continuing operations consists of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2019
|
|
2018
|
|
2017
|
Current:
|
|
|
|
|
|
|
Federal
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
State
|
|
12
|
|
|
70
|
|
|
1
|
|
Foreign
|
|
1,277
|
|
|
2,920
|
|
|
2,230
|
|
|
|
1,289
|
|
|
2,990
|
|
|
2,231
|
|
Deferred:
|
|
|
|
|
|
|
Federal
|
|
(3
|
)
|
|
(145
|
)
|
|
(155
|
)
|
State
|
|
—
|
|
|
—
|
|
|
—
|
|
Foreign
|
|
(356
|
)
|
|
(1,524
|
)
|
|
886
|
|
|
|
(359
|
)
|
|
(1,669
|
)
|
|
731
|
|
Total
|
|
$
|
930
|
|
|
$
|
1,321
|
|
|
$
|
2,962
|
|
The significant differences between the U.S. federal statutory tax rate and the Company’s effective income tax expense for earnings (in thousands) are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2019
|
|
2018
|
|
2017
|
Statutory federal income tax rate
|
|
$
|
(2,814
|
)
|
|
$
|
981
|
|
|
$
|
2,631
|
|
State income taxes, net of federal effect
|
|
(134
|
)
|
|
(285
|
)
|
|
(62
|
)
|
Net operating loss limitation
|
|
—
|
|
|
—
|
|
|
2,975
|
|
Adjustment to deferred taxes
|
|
480
|
|
|
939
|
|
|
301
|
|
Change in deferred tax asset valuation allowance
|
|
529
|
|
|
(2,867
|
)
|
|
(15,338
|
)
|
Change in tax law
|
|
1,385
|
|
|
(992
|
)
|
|
13,850
|
|
Foreign tax rate differential
|
|
947
|
|
|
1,306
|
|
|
(899
|
)
|
Compensation and equity adjustments
|
|
643
|
|
|
1,474
|
|
|
—
|
|
Acquisition earnout adjustment
|
|
2
|
|
|
(320
|
)
|
|
87
|
|
Other permanent differences
|
|
116
|
|
|
183
|
|
|
(682
|
)
|
Withholding taxes
|
|
169
|
|
|
591
|
|
|
342
|
|
Changes in uncertain tax positions
|
|
(12
|
)
|
|
19
|
|
|
(429
|
)
|
Return to provision adjustments
|
|
(278
|
)
|
|
257
|
|
|
155
|
|
Other, net
|
|
(103
|
)
|
|
35
|
|
|
31
|
|
Total
|
|
$
|
930
|
|
|
$
|
1,321
|
|
|
$
|
2,962
|
|
The tax effects of temporary differences and carry-forwards that give rise to deferred tax assets and liabilities consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2019
|
|
2018
|
Deferred income tax assets:
|
|
|
|
|
Accounts payable and accrued expenses
|
|
$
|
704
|
|
|
$
|
714
|
|
Accrued payroll and related expenses
|
|
975
|
|
|
2,315
|
|
Stock-based compensation expense
|
|
2,349
|
|
|
2,336
|
|
Depreciation of property and equipment
|
|
927
|
|
|
853
|
|
Capitalized software
|
|
1,566
|
|
|
119
|
|
Unbilled receivables and refund liabilities
|
|
—
|
|
|
97
|
|
Operating loss carry-forwards of foreign subsidiary
|
|
9,733
|
|
|
9,484
|
|
Federal operating loss carry-forwards
|
|
18,042
|
|
|
17,109
|
|
State operating loss carry-forwards
|
|
4,678
|
|
|
4,537
|
|
Operating lease liabilities
|
|
2,777
|
|
|
—
|
|
Other
|
|
1,311
|
|
|
1,624
|
|
Gross deferred tax assets
|
|
43,062
|
|
|
39,188
|
|
Less valuation allowance
|
|
31,975
|
|
|
31,597
|
|
Gross deferred tax assets net of valuation allowance
|
|
11,087
|
|
|
7,591
|
|
Deferred income tax liabilities:
|
|
|
|
|
Intangible assets
|
|
587
|
|
|
1,269
|
|
Operating lease right-of-use asset
|
|
2,731
|
|
|
—
|
|
Branch offset
|
|
2,448
|
|
|
1,900
|
|
CFC earnings
|
|
767
|
|
|
851
|
|
Prepaid expenses
|
|
862
|
|
|
676
|
|
Unbilled receivables and refund liabilities
|
|
344
|
|
|
—
|
|
Other
|
|
55
|
|
|
—
|
|
Gross deferred tax liabilities
|
|
7,794
|
|
|
4,696
|
|
Net deferred tax assets
|
|
$
|
3,293
|
|
|
$
|
2,895
|
|
Our reported effective tax rates on income approximated (6.9)% in 2019, 28.3% in 2018, and 39.4% in 2017. Reported income tax expense in each year primarily results from taxes on the income of foreign subsidiaries. The effective tax rates generally differ from the expected tax rate primarily due to the Company’s deferred tax asset valuation allowance on the domestic earnings and taxes on income of foreign subsidiaries.
On December 22, 2017, the Tax Cuts and Jobs Act (the "Tax Act") was signed into law making significant changes to the Internal Revenue Code. The legislation contains several key provisions that impacted the consolidated financial statements for the year ended December 31, 2017. Additionally, in December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (SAB 118), which allowed us to record provisional amounts during a measurement period not to extend beyond one year of the enactment date. As of December 31, 2018, we completed an analysis related to the Tax Act in accordance with SAB 118 and determined that there was no additional adjustment required. Additionally, no adjustments were made in 2019.
The Tax Act contains several key provisions that affect us. The Alternative Minimum Tax (“AMT”) was repealed for tax years beginning after December 31, 2017 and the AMT credit was to be refundable in future years. Because 50% of this credit was to be refundable on the 2018 tax return, that portion was reclassified to a current asset on the balance sheet at the end of the 2018 calendar year, and because the credit was not claimed on the tax return, it will remain a current asset as it will be claimed on the 2019 calendar year tax return. The Global Intangible Low Tax Income Tax (“GILTI”) is a U.S. minimum tax on the foreign earnings on intangible assets. The Company expects a GILTI inclusion of $4.4 million to be recognized on the Company's 2019 calendar year-end U.S. tax return (an increase to taxable income that will be absorbed by the Company's NOL carryforward), which will have a 6.9% impact on the effective rate for the year ended December 31, 2019.
We undertook a detailed review of our deferred taxes and it was determined with the exception of the deferred tax assets associated with the AMT credit described above, a valuation allowance was required for all other U.S. deferred tax assets. We released the valuation allowance on our Hungarian branch's (PRGX Europe, Inc.) deferred tax assets during the year ended December 31, 2019, which had an immaterial impact on the effective rate. We reduce our deferred tax assets by a valuation allowance if it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences are deductible. In making this determination, we consider all available positive and negative evidence affecting specific deferred tax assets, including our past and anticipated future performance, the reversal of deferred tax liabilities, the length of carryback and carryforward periods and the implementation of tax planning strategies. Since this evaluation requires consideration of future events, significant judgment is required in making the evaluation, and our conclusion could be materially different should certain of our expectations not be met. The balance of our valuation allowance was $32.0 million as of December 31, 2019, representing a change of $0.4 million from the valuation allowance of $31.6 million recorded as of December 31, 2018. The primary driver of the change in the valuation allowance was an additional valuation allowance recorded on the additional NOL generated in the U.S. in 2019.
In 2017, management determined that a valuation allowance was no longer required against the deferred tax assets of certain of its U.S. branches in Spain, Taiwan, Thailand and Mexico. As of December 31, 2017, we had gross deferred tax assets of $0.9 million relating to those foreign subsidiaries. The benefit of these deferred tax assets is reflected as a credit of $0.2 million to tax expense during the year ended December 31, 2017.
In 2018, management determined that a valuation allowance was no longer required against the deferred tax assets of the UK subsidiary and U.S. branch in France. As of December 31, 2018, we had gross deferred tax assets of $6.6 million relating to those foreign subsidiaries. The benefit of these deferred tax assets is reflected as a credit of $1.2 million to tax expense during the year ended December 31, 2018.
In 2019, management determined that a valuation allowance was no longer required against the deferred tax assets of the U.S. branch in Hungary. As of December 31, 2019, we had immaterial gross deferred tax assets relating to the U.S. branch in Hungary. The benefit of the deferred assets is reflected as an immaterial credit to tax expense during the year ended December 31, 2019.
As of December 31, 2019, we had approximately $85.9 million of U.S. federal loss carry-forwards available to reduce future U.S. federal taxable income. Approximately $81.3 million of the U.S. federal loss carry-forwards expire between 2026 and 2035. The remaining $4.6 million of U.S. federal loss carry-forwards do not expire. As of December 31, 2019, we had approximately $61.9 million of state loss carry-forwards available to reduce future state taxable income. The state loss carry-forwards expire between 2022 and 2037 and are subject to certain limitations. The U.S. federal and state loss carry-forwards at December 31, 2019, reflect adjustments for prior period write-downs associated with ownership changes.
Generally, we have not provided deferred taxes on the undistributed earnings of international subsidiaries as we consider these earnings to be permanently reinvested. As it relates to the earnings of our Brazilian subsidiary, we assert that we are not permanently reinvested. We did not provide additional incremental tax expense on these amounts as our Brazilian subsidiary did not have undistributed earnings during the year.
On December 30, 2016, the Company experienced an ownership change as defined under Section 382 of the Internal Revenue Code (“IRC”). This ownership change resulted in an annual IRC Section 382 limitation that limits the use of certain tax attribute carry-forwards and also resulted in the write-off of certain deferred tax assets and the related valuation allowances that the Company recorded in 2017. The Company has performed its assessment and has determined that $87.3 million of the gross federal net operating losses outstanding as of December 30, 2016 will be available for use going-forward. The Company utilized $6.0 million of these losses on the 2017 U.S. federal tax return and the remaining $81.3 million remains available.
A reconciliation of our beginning and ending amount of unrecognized tax benefits and related accrued interest thereon is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Unrecognized Tax Benefits
|
|
Accrued Interest and Penalties
|
Balance at January 1, 2017
|
|
$
|
497
|
|
|
$
|
154
|
|
Additions based on tax positions related to the current year
|
|
—
|
|
|
—
|
|
Additions based on tax positions related to the prior years
|
|
116
|
|
|
19
|
|
Decrease based on payments made during the year
|
|
—
|
|
|
—
|
|
Decreases based on tax positions related to the prior years
|
|
$
|
(420
|
)
|
|
$
|
(145
|
)
|
Balance at December 31, 2017
|
|
$
|
193
|
|
|
$
|
28
|
|
Additions based on tax positions related to the current year
|
|
4
|
|
|
—
|
|
Additions based on tax positions related to the prior years
|
|
10
|
|
|
6
|
|
Decreases based on payments made during the year
|
|
—
|
|
|
—
|
|
Decreases based on tax positions related to the prior years
|
|
—
|
|
|
—
|
|
Balance at December 31, 2018
|
|
$
|
207
|
|
|
$
|
34
|
|
Additions based on tax positions related to the current year
|
|
—
|
|
|
—
|
|
Additions based on tax positions related to the prior years
|
|
—
|
|
|
15
|
|
Decreases based on payments made during the year
|
|
—
|
|
|
—
|
|
Decreases based on tax positions related to the prior years
|
|
(19
|
)
|
|
(8
|
)
|
Balance at December 31, 2019
|
|
$
|
188
|
|
|
$
|
41
|
|
Due to the complexity of the tax rules underlying these unrecognized tax benefits, and the unclear timing of tax audits, tax agency determinations, and other events, we cannot establish reasonably reliable estimates for the periods in which the cash settlement of these liabilities will occur.
We file U.S. federal, state, and foreign income tax returns in jurisdictions with varying statutes of limitations. As of December 31, 2019, the 2016 through 2018 tax years generally remain subject to examination by federal and most state and foreign tax authorities. The use of net operating losses generated in tax years prior to 2016 may also subject returns for those years to examination.
(8) EMPLOYEE BENEFIT PLANS
We maintain a defined contribution retirement plan (the "Plan") in accordance with Section 401(k) of the Internal Revenue Code, which allows eligible participating employees to defer a portion of their annual compensation and contribute such amount to one or more investment funds. The Plan provides for a discretionary matching contribution by the Company as determined by management and approved by the Board of Directors each plan year. The Company's current practice is to match 50% of the annual employee's contribution, up to but not exceeding the lesser of 6% of the employee’s annual compensation or $3,000. Discretionary matching contributions made by the Company to a participant's account are vested once a participant has attained three or more years of service. The Company contributed to the Plan approximately $1.0 million in 2019, $0.9 million in 2018, and $0.8 million in 2017.
(9) STOCK REPURCHASES
On February 21, 2014, our Board of Directors authorized a stock repurchase program under which we could repurchase up to $10.0 million of our common stock from time to time through March 31, 2015. Since the original 2014 authorization of the stock repurchase program, our Board of Directors modified the program from time to time to extend the term and increase the repurchase limit to $75.0 million. The program expired on December 31, 2019. During the year ended December 31, 2019, we repurchased 0.7 million shares of our common stock for $4.7 million. During the year ended December 31, 2018, we repurchased 0.4 million shares of our common stock for $4.1 million.
(10) COMMITMENTS AND CONTINGENCIES
Legal Proceedings
We are party to a variety of legal proceedings arising in the normal course of business. While the results of these proceedings cannot be predicted with certainty, management believes that the final outcome of these proceedings will not have a material adverse effect on our financial position, results of operations or cash flows.
(11) STOCK-BASED COMPENSATION
Plan Summary
During 2019, the Company had two shareholder-approved stock-based compensation plans under which outstanding equity awards have been granted: (1) the 2008 Equity Incentive Plan (“2008 EIP”); and (2) the 2017 Equity Incentive Compensation Plan (“2017 EICP”) (collectively, the “Plans”).
2008 EIP Awards
During the first quarter of 2008, the Board of Directors of the Company adopted the 2008 EIP, which was approved by the shareholders at the annual meeting of the shareholders on May 29, 2008. The 2008 EIP authorized the grant of incentive and non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and other incentive awards. Pursuant to amendments to the 2008 EIP that were approved by the Board of Directors and the Company's shareholders, 10,600,000 shares were reserved for issuance under the 2008 EIP to award grants to key employees, directors and service providers. The options granted pursuant to the 2008 EIP generally had seven year terms and vested in equal annual increments over the vesting period, which typically was three years for employees and one year for directors. No further awards can be granted from the 2008 EIP following the approval of the 2017 EICP by shareholders on June 27, 2017.
2017 EICP Awards
In April 2017, the Board of Directors adopted the 2017 EICP, which was approved by the shareholders at the annual meeting of the shareholders on June 27, 2017. The 2017 EICP applies to awards granted on or after June 27, 2017. Under the 2017 EICP, the Company may grant incentive and non-qualified stock options, stock appreciation rights, restricted stock, deferred stock, restricted stock units, performance units, performance shares, dividend equivalents, bonus shares, and other stock-based or cash-based awards. The maximum number of shares of common stock that may be issued pursuant to the awards under the 2017 EICP is 3,400,000 shares plus that number of shares of common stock subject to awards granted under the 2008 EIP that were outstanding when the 2017 EICP became effective and that subsequently terminate without deleting of the shares, whether by lapse, forfeiture, cancellation, or otherwise. The options granted to date pursuant to the 2017 EICP have a term of seven years. As of December 31, 2019 there were approximately 1.8 million shares available for future grants under the 2017 EICP.
Grants
Option Awards
The following table summarizes stock option awards granted during the years ended December 31, 2019, 2018, and 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grantee
Type
|
|
Number of
Options
Granted
|
|
Vesting Period
|
|
Weighted
Average
Exercise Price
|
|
Weighted
Average Grant
Date Fair Value
|
2019
|
|
|
|
|
|
|
|
|
Employee inducement (1)
|
|
400,000
|
|
|
3 years
|
|
$
|
8.21
|
|
|
$
|
2.64
|
|
|
|
|
|
|
|
|
|
|
2018
|
|
|
|
|
|
|
|
|
Employee inducement (1)
|
|
535,000
|
|
|
3 years
|
|
$
|
8.91
|
|
|
$
|
2.89
|
|
|
|
|
|
|
|
|
|
|
2017
|
|
|
|
|
|
|
|
|
Director group
|
|
90,566
|
|
|
1 year or less
|
|
$
|
6.34
|
|
|
$
|
3.49
|
|
Director group(2)
|
|
35,000
|
|
|
3 years
|
|
$
|
6.25
|
|
|
$
|
3.50
|
|
CEO grant
|
|
500,000
|
|
|
4 years
|
|
$
|
7.35
|
|
|
$
|
2.36
|
|
Employee group
|
|
30,000
|
|
|
3 years
|
|
$
|
7.25
|
|
|
$
|
3.99
|
|
Employee inducement (1)
|
|
335,000
|
|
|
3 years
|
|
$
|
6.19
|
|
|
$
|
3.41
|
|
|
|
(1)
|
The Company granted non-qualified stock options outside its existing stock-based compensation plans to certain employees in connection with the employees joining the Company.
|
|
|
(2)
|
The Company granted non-qualified stock options to one director in connection with the director joining the Company's board of directors.
|
Nonvested Stock Awards
The following table summarizes nonvested stock awards granted during the years ended December 31, 2019, 2018 and 2017:
|
|
|
|
|
|
|
|
|
|
|
Grantee
Type
|
|
Number of Stock Awards
Granted
|
|
Vesting Period
|
|
Weighted
Average Grant
Date Fair Value
|
2019
|
|
|
|
|
|
|
Director group
|
|
92,735
|
|
|
2 years or less
|
|
$
|
6.47
|
|
Employee group (1)
|
|
1,304,472
|
|
|
3 years or less
|
|
$
|
5.88
|
|
Employee inducement (2)
|
|
212,813
|
|
|
3 years or less
|
|
$
|
7.03
|
|
|
|
|
|
|
|
|
2018
|
|
|
|
|
|
|
Director group
|
|
64,545
|
|
|
1 year or less
|
|
$
|
9.45
|
|
Employee group (1)
|
|
488,685
|
|
|
3 years or less
|
|
$
|
9.56
|
|
Employee inducement (2)
|
|
160,516
|
|
|
3 years or less
|
|
$
|
8.95
|
|
|
|
|
|
|
|
|
2017
|
|
|
|
|
|
|
Director group
|
|
51,179
|
|
|
1 year or less
|
|
$
|
6.35
|
|
Employee group (3)
|
|
641,751
|
|
|
3 years or less
|
|
$
|
6.31
|
|
Employee inducement (2)
|
|
100,000
|
|
|
3 years or less
|
|
$
|
6.33
|
|
|
|
(1)
|
The Company granted nonvested performance-based stock awards (restricted stock units), restricted stock awards, and restricted stock units in 2019 and 2018 to certain key employees.
|
|
|
(2)
|
The Company granted nonvested performance-based stock awards (restricted stock units) and restricted stock awards to certin employees in connection with the employees joining the Company.
|
|
|
(3)
|
The Company granted nonvested performance-based stock awards (restricted stock units), restricted stock units and restricted stock awards in the first quarter of 2017 to twelve executive officers totaling 458,000 units. During the second quarter of 2017, the Company issued 183,751 restricted stock awards and restricted stock units to key employees.
|
Nonvested stock awards, including both restricted stock and restricted stock units, generally are nontransferable until vesting and the holders are entitled to receive dividends with respect to the nonvested shares, provided the shares ultimately vest. Prior to vesting, the grantees of restricted stock are entitled to vote the shares, but the grantees of restricted stock units are not entitled to vote the shares. Generally, nonvested stock awards, excluding those whose vesting is performance-based, vest in equal annual increments over the vesting period, which typically is three years for employees and one year for directors. Performance-based stock awards vest based on the achievement of certain performance objectives.
Performance-Based Restricted Stock Units
The Company grants its executive officers and certain other employees performance-based restricted stock units ("PBUs") which will vest, if at all, only upon attainment of certain levels of Company financial performance over a performance period, which is generally two years. The purpose of these grants is to align the interests of executive officers and employees with the long-term interests of the shareholders.
2019-2020 performance period PBU grants
During 2019, the Company granted 484,000 PBUs under the 2017 EICP and 78,000 PBUs outside of the existing stock-based compensation plan as an inducement for employment. If vested, 100% of the vested Units will be paid in whole shares of common stock. 35% of the PBUs vest and become payable based on the cumulative revenue from continuing operations and 65% of the PBUs vest and become payable based on the cumulative adjusted EBITDA from continuing operations that the Company achieves, in each case, for the two-year performance period ending December 31, 2020. At the threshold performance level, 60% of the PBUs will become vested and payable; at the target performance level, 100% of the PBUs will become vested and payable; and at the maximum performance level, 150% of the PBUs will become vested and payable. If performance falls between the stated performance levels the percentage of PBUs that shall become vested and payable will be based on a straight-line interpolation between such stated performance levels (although the PBUs may not become vested and payable for more than 150% of the PBUs
and no PBUs shall become vested and payable if performance does not equal or exceed the applicable threshold performance level).
Stock-based compensation expense for these PBUs is being recognized at the target level of financial performance, as if 100% of the awards will vest.
2018-2019 performance period PBU grants
During 2019, the Company granted 19,377 PBUs outside of the existing stock-based compensation plan as inducement for employment. During 2018, the Company granted certain employees 246,278 PBUs. If vested, 100% of the vested PBUs will be paid in whole shares of common stock. 50% of the PBUs vest and become payable based on the cumulative revenue from continuing operations,35% of the PBUs vest and become payable based on the cumulative adjusted EBITDA from continuing operations and 15% of the PBUs vest and become payable based on the cumulative Adjacent Services revenue that the Company achieves, in each case, for the two-year performance period ending December 31, 2019. At the threshold performance level, 35% of the PBUs will become vested and payable; at the target performance level, 100% of the PBUs will become vested and payable; and at the maximum performance level, 150% of the PBUs will become vested and payable. If performance falls between the stated performance levels the percentage of PBUs that shall become vested and payable will be based on a straight-line interpolation between such stated performance levels (although the PBUs may not become vested and payable for more than 150% of the PBUs and no PBUs shall become vested and payable if performance does not equal or exceed the applicable threshold performance level).
Prior to the third quarter of 2019, these PBUs had been expensed at the target performance level, as if 100% of the awards will vest. During the third quarter of 2019, management determined that it was not probable that the threshold performance levels for two of the three performance objectives would be achieved and the Company reversed approximately $0.8 million of expense. In the fourth quarter of 2019, management further determined that the threshold performance level for the third performance objective would not be achieved and reversed an additional $0.1 million of expense.
2017-2018 performance period PBU grants
During 2018 and 2017, the Company granted 386,550 PBUs to certain employees. During the first quarter of 2019, the Company issued 203,524 shares of common stock in connection with the vesting of these awards.
The following table summarizes the PBUs granted during the years ended December 31, 2019, 2018 and 2017:
|
|
|
|
|
|
|
Total PBUs Granted
|
PBUs to be Settled in Common Stock (1)
|
2019
|
581,377
|
|
581,377
|
|
2018
|
299,028
|
|
299,028
|
|
2017
|
333,800
|
|
333,800
|
|
|
|
(1)
|
Represents the number of shares of common stock to be issued assuming that the PBUs vest at the target performance level.
|
Stock Appreciation Rights
During 2018, certain employees were granted stock appreciation rights ("SARs") covering 350,000 shares of the Company's common stock under the 2017 EICP. The SARs vested on March 1, 2020. 25% of the SARs may be exercised on the last day of each of the first, second and third calendar quarters in 2020. Within 30 days after the SARs are exercised, the Company must settle the exercised SARs in a cash payment equal to the excess of (i) the lesser of the fair market value, as of the date on which the SARs are exercised, or $18 per share, over (ii) $9.15 per share, less any applicable tax withholding. Vested SARs not exercised during any previous quarter will remain outstanding and be automatically exercised as of December 31, 2020.
Summary of Activity
A summary of option activity as of December 31, 2019, and changes during the year then ended is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options
|
|
Shares
|
|
Weighted-
Average
Exercise
Price
(Per Share)
|
|
Weighted-
Average
Remaining
Contractual
Term
|
|
Aggregate
Intrinsic
Value
($ 000’s)
|
Outstanding at January 1, 2019
|
|
2,850,817
|
|
|
$
|
6.84
|
|
|
3.74 years
|
|
$
|
7,384
|
|
Granted
|
|
400,000
|
|
|
8.21
|
|
|
|
|
|
Exercised
|
|
(45,380
|
)
|
|
4.87
|
|
|
|
|
$
|
119
|
|
Forfeited
|
|
(243,337
|
)
|
|
7.75
|
|
|
|
|
|
Expired
|
|
(115,092
|
)
|
|
7.69
|
|
|
|
|
|
Outstanding at December 31, 2019
|
|
2,847,008
|
|
|
$
|
6.95
|
|
|
2.65 years
|
|
$
|
66
|
|
Exercisable at December 31, 2019
|
|
1,978,008
|
|
|
$
|
6.57
|
|
|
1.62 years
|
|
$
|
66
|
|
The weighted-average grant date fair value of options granted was $2.64 per share in 2019, $2.89 per share in 2018 and $2.91 per share in 2017. The total intrinsic value of options exercised was $0.1 million in 2019, $1.6 million in 2018 and $0.3 million in 2017.
For time-vested option grants that resulted in compensation expense recognition, we used the following assumptions in our Black-Scholes valuation models:
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
2019
|
|
2018
|
|
2017
|
Risk-free interest rates (1)
|
|
2.15% - 2.36%
|
|
2.30% - 2.99%
|
|
1.38% - 1.96%
|
Dividend yields (2)
|
|
—%
|
|
—%
|
|
—%
|
Volatility factor of expected market price (3)
|
|
36.5% - 37.2%
|
|
36.2% - 37.1%
|
|
54.0% - 74.9%
|
Weighted-average expected term of options (4)
|
|
4 years
|
|
4 years
|
|
2.2 - 4 years
|
Forfeiture rate (5)
|
|
—%
|
|
—%
|
|
—%
|
|
|
(1)
|
The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant for periods corresponding to the expected term of the options.
|
|
|
(2)
|
The Company has not historically declared dividends.
|
|
|
(3)
|
The expected volatility is based on the historical volatility of the Company's stock.
|
|
|
(4)
|
The expected term represents the weighted average period of time that the stock options are expected to be outstanding, giving consideration to the vesting schedules.
|
|
|
(5)
|
The Company accounts for forfeitures as they occur rather than estimating expected forfeitures.
|
A summary of nonvested stock awards (including restricted stock, restricted stock units and performance-based restricted stock units) activity as of December 31, 2019 and changes during the year then ended is presented below:
|
|
|
|
|
|
|
|
|
Nonvested Stock
|
|
Shares
|
|
Weighted
Average Grant
Date Fair Value
(Per Share)
|
Nonvested at January 1, 2019
|
|
965,950
|
|
|
$
|
8.18
|
|
Granted
|
|
1,610,020
|
|
|
6.07
|
|
Vested
|
|
(510,327
|
)
|
|
7.60
|
|
Forfeited
|
|
(290,612
|
)
|
|
8.12
|
|
Nonvested at December 31, 2019
|
|
1,775,031
|
|
|
$
|
6.41
|
|
The weighted-average grant date fair value of nonvested stock awards (restricted stock and restricted stock units) granted was $6.07 per share in 2019, $9.42 per share in 2018 and $6.32 per share in 2017. The total vest date fair value of stock awards vested during the year was $3.6 million in 2019, $12.7 million in 2018 and $0.3 million in 2017.
Stock-based compensation expense was $4.9 million in 2019, $5.1 million in 2018, and $7.1 million in 2017. We include these charges in Selling, general and administrative expenses in the accompanying Consolidated Statements of Operations. The total income tax benefit recognized in our Consolidated Statements of Operations was $1.2 million, $1.3 million and $2.7 million in 2019, 2018 and 2017, respectively.
Total unrecognized compensation expense related to nonvested stock-based compensation as of December 31, 2019 is as follows (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
Restricted
|
|
Restricted
|
|
Performance-Based Restricted
|
|
|
|
Options
|
|
Stock Awards
|
|
Stock Units
|
|
Stock Units
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
Unrecognized compensation expense
|
$
|
1,488
|
|
|
$
|
3,989
|
|
|
$
|
674
|
|
|
$
|
2,267
|
|
|
$
|
8,418
|
|
Weighted-average remaining recognition period (in years)
|
1.9
|
|
|
2.0
|
|
|
1.4
|
|
|
1.0
|
|
|
1.7
|
|
(12) QUARTERLY RESULTS (UNAUDITED)
The following tables set forth certain unaudited condensed consolidated quarterly financial data for each of the last eight quarters during our fiscal years ended December 31, 2019 and 2018. We have derived the information from unaudited condensed consolidated financial statements that, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of such quarterly information. The operating results for any quarter are not necessarily indicative of the results to be expected for any future period. The quarterly results are updated for continuing operations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019 Quarter Ended
|
|
2018 Quarter Ended
|
|
|
Mar. 31
|
|
June 30
|
|
Sept. 30
|
|
Dec. 31
|
|
Mar. 31
|
|
June 30
|
|
Sept. 30
|
|
Dec. 31
|
|
|
(In thousands, except per share data)
|
Revenue, net
|
|
$
|
38,804
|
|
|
$
|
41,974
|
|
|
$
|
42,290
|
|
|
$
|
46,690
|
|
|
$
|
36,721
|
|
|
$
|
42,102
|
|
|
$
|
43,320
|
|
|
$
|
49,633
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue
|
|
25,235
|
|
|
26,312
|
|
|
25,539
|
|
|
23,090
|
|
|
24,797
|
|
|
27,389
|
|
|
26,146
|
|
|
26,493
|
|
Selling, general and administrative expenses
|
|
13,917
|
|
|
15,748
|
|
|
13,544
|
|
|
14,390
|
|
|
11,264
|
|
|
12,809
|
|
|
12,521
|
|
|
13,862
|
|
Depreciation of property, equipment and software assets
|
|
2,203
|
|
|
2,381
|
|
|
2,648
|
|
|
2,749
|
|
|
1,223
|
|
|
2,360
|
|
|
1,713
|
|
|
2,074
|
|
Amortization of intangible assets
|
|
862
|
|
|
872
|
|
|
864
|
|
|
867
|
|
|
788
|
|
|
864
|
|
|
872
|
|
|
871
|
|
Acquisition-related adjustments (income) loss
|
|
—
|
|
|
—
|
|
|
(250
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,640
|
)
|
|
12
|
|
Impairment charges
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,073
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Total operating expenses
|
|
42,217
|
|
|
45,313
|
|
|
42,345
|
|
|
51,169
|
|
|
38,072
|
|
|
43,422
|
|
|
39,612
|
|
|
43,312
|
|
Operating (loss) income from continuing operations
|
|
(3,413
|
)
|
|
(3,339
|
)
|
|
(55
|
)
|
|
(4,479
|
)
|
|
(1,351
|
)
|
|
(1,320
|
)
|
|
3,708
|
|
|
6,321
|
|
Foreign currency transaction losses (gains) on short-term intercompany balances
|
|
206
|
|
|
(77
|
)
|
|
905
|
|
|
(736
|
)
|
|
(220
|
)
|
|
880
|
|
|
70
|
|
|
272
|
|
Interest expense, net
|
|
473
|
|
|
592
|
|
|
376
|
|
|
376
|
|
|
398
|
|
|
486
|
|
|
416
|
|
|
363
|
|
Other (income) loss
|
|
(19
|
)
|
|
11
|
|
|
4
|
|
|
1
|
|
|
12
|
|
|
5
|
|
|
(1
|
)
|
|
5
|
|
(Loss) income from continuing operations before income taxes
|
|
(4,073
|
)
|
|
(3,865
|
)
|
|
(1,340
|
)
|
|
(4,120
|
)
|
|
(1,541
|
)
|
|
(2,691
|
)
|
|
3,223
|
|
|
5,681
|
|
Income tax expense (benefit)
|
|
168
|
|
|
311
|
|
|
202
|
|
|
249
|
|
|
787
|
|
|
189
|
|
|
597
|
|
|
(252
|
)
|
Net (loss) income from continuing operations
|
|
(4,241
|
)
|
|
(4,176
|
)
|
|
(1,542
|
)
|
|
(4,369
|
)
|
|
(2,328
|
)
|
|
(2,880
|
)
|
|
2,626
|
|
|
5,933
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic (loss) earnings per common share from continuing operations (1)
|
|
$
|
(0.19
|
)
|
|
$
|
(0.18
|
)
|
|
$
|
(0.07
|
)
|
|
$
|
(0.19
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
(0.13
|
)
|
|
$
|
0.11
|
|
|
$
|
0.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted (loss) earnings per common share from continuing operations (1)
|
|
$
|
(0.19
|
)
|
|
$
|
(0.18
|
)
|
|
$
|
(0.07
|
)
|
|
$
|
(0.19
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
(0.13
|
)
|
|
$
|
0.11
|
|
|
$
|
0.26
|
|
|
|
(1)
|
We calculate each quarter as a discrete period; the sum of the four quarters may not equal the calculated full-year amount.
|
(13) SUBSEQUENT EVENT
On March 9, 2020, the Company's Board of Directors approved a stock repurchase program under which PRGX may repurchase up to $20 million of its outstanding common stock from time to time through December 31, 2021. The Company’s prior repurchase program expired on December 31, 2019.
ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
ITEM 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company carried out an evaluation, under the supervision and with the participation of its management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in the Exchange Act Rule 13a-15(e)) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective as of December 31, 2019.
Changes in internal controls over financial reporting
There was no change in the Company’s internal control over financial reporting that occurred during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
Management’s Annual Report on Internal Control Over Financial Reporting
The Company’s management is responsible for establishing and maintaining an adequate system of internal control over financial reporting, as defined in the Exchange Act Rule 13a-15(f). Our internal control system is designed to provide reasonable assurance regarding the preparation and fair presentation of financial statements for external purposes in accordance with generally accepted accounting principles. All internal control systems, no matter how well designed, have inherent limitations and can provide only reasonable assurance that the objectives of the internal control system are met. Under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, the Company conducted an assessment of the effectiveness of internal control over financial reporting based on the framework (2013 Framework) in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on the assessment, management concluded that, as of December 31, 2019, the Company’s internal control over financial reporting is effective. The Company’s internal control over financial reporting as of December 31, 2019 has been audited by BDO USA, LLP, an independent registered public accounting firm, as stated in their report which is included herein, which expresses an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2019.
Management’s report shall not be deemed filed for purposes of Section 18 of the Exchange Act.
Report of Independent Registered Public Accounting Firm
Shareholders and Board of Directors
PRGX Global, Inc. and Subsidiaries
Atlanta, Georgia
Opinion on Internal Control over Financial Reporting
We have audited PRGX Global, Inc. and subsidiaries’ (the “Company”) internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “COSO criteria”). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated balance sheets of the Company as of December 31, 2019 and 2018, the related consolidated statements of operations, comprehensive (loss) income, shareholders’ equity, and cash flows for each of the three years in the period ended December 31, 2019, and the related notes and financial statement schedule listed in the accompanying index and our report dated March 12, 2020 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying “Item 9A, Management’s Annual Report on Internal Control Over Financial Reporting”. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit of internal control over financial reporting in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ BDO USA, LLP
Atlanta, Georgia
March 12, 2020